(Q38287322)

1 September 2017

title

Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity (English)

1 reference

1 September 2017

0 references

1 reference

Tassone F

1

1 reference

1 September 2017

Grottoli S

2

1 reference

1 September 2017

Rossetto R

3

1 reference

1 September 2017

Maccagno B

4

1 reference

1 September 2017

Gauna C

5

1 reference

1 September 2017

Giordano R

6

1 reference

1 September 2017

Ghigo E

7

1 reference

1 September 2017

Maccario M

8

1 reference

1 September 2017

publication date

1 June 2002

1 reference

Journal of Endocrinological Investigation

1 September 2017

published in

1 reference

1 September 2017

volume

25

1 reference

1 September 2017

issue

6

1 reference

1 September 2017

page(s)

551-556

1 reference

Endocrine function in human obesity

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Free insulin-like growth factors in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Neuroendocrine regulation and actions of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

The Central Melanocortin System and Energy Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Growth-hormone release by glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Glucagon Stimulation of Human Growth Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Hypoglycemia: a potent stimulus to secretion of growth hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Biologic activities of growth hormone secretagogues in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Regulation of pituitary-adrenocortical activity by free fatty acids in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345499

Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans

21 January 2018

1 reference

12 December 2020

Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST)

1 reference

12 December 2020

Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans

1 reference

12 December 2020

The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution

1 reference

12 December 2020

Growth Hormone Response to Intramuscular Glucagon

1 reference

12 December 2020

In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose

1 reference

12 December 2020

Antidiabetic sulfonylurea enhances secretagogue-induced adrenocorticotropin secretion and proopiomelanocortin gene expression in vitro

1 reference

12 December 2020

Neuroendocrine abnormalities in visceral obesity

1 reference

12 December 2020

ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome

1 reference

12 December 2020

Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses

1 reference

12 December 2020

Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

1 reference

12 December 2020

A preview of growth hormone stimulation tests in children

1 reference

12 December 2020

Altered neuroregulation of GH secretion in viscerally obese premenopausal women

1 reference

12 December 2020

Comparisons among old and new provocative tests of GH secretion in 178 normal adults

1 reference

12 December 2020

Low concentrations of insulin-like growth factor-I in abdominal obesity

1 reference

12 December 2020

Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?

1 reference

12 December 2020

GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism

1 reference

12 December 2020

Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects

1 reference

12 December 2020

Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.

1 reference

12 December 2020

Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women

1 reference

12 December 2020

Glucagon-induced growth hormone release in children

1 reference

12 December 2020

Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study

1 reference

12 December 2020

About the effects of glucagon on growth hormone release

1 reference

12 December 2020

The assessment of growth hormone status in normal young adult males using a variety of provocative agents

1 reference

12 December 2020

Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity

1 reference

12 December 2020

Regulation of growth hormone secretion by signals produced by the adipose tissue.

1 reference

12 December 2020

The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors

1 reference

12 December 2020

Growth hormone in obesity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345499

1 reference

1 September 2017

1 reference